Viewing Study NCT00903461


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2025-12-30 @ 3:14 AM
Study NCT ID: NCT00903461
Status: TERMINATED
Last Update Posted: 2017-02-15
First Post: 2009-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma
Sponsor: University of Pittsburgh
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module